Investor's Business Daily on MSN22h
Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot causes excessive bone mineral density loss.
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback